News / Wed 12 May 2021
medtech
Biotech unicorn Oxford Nanopore raises £195M ahead of London IPO; valued at £2.48B
Based out of Oxford, Oxford Nanopore Technologies is the next-generation DNA/RNA sequencing technolo...
News
/ Thu 6 May 2021
Tech rounds above $100M: The top-funded companies in April 2021
During the ongoing pandemic crisis, funding announcements from startups are a beacon of hope. The Eu...
News
/ Fri 30 Apr 2021
Johnson & Johnson backs $11M seed financing in Cambridge-based drug developer
Mestag Therapeutics, a breakthrough inflammatory disease and immuno-oncology company announced its l...
News
/ Thu 29 Apr 2021
Bill Gates-backed Oxford drug developer raises $525M funding led by Softbank
Based out of Oxford, Exscientia is a clinical-stage pharmatech company that uses artificial intellig...
News
/ Wed 28 Apr 2021
Cambridge university spin-off HexagonFab secures £1.9M for next-gen biopharmaceuticals
HexagonFab, a spin-off of the University of Cambridge, has secured a £1.9 million seed funding roun...
News
/ Tue 20 Apr 2021
British medtech Oxford Endovascular secures £7.2M to treat brain aneurysms
Oxford Endovascular is a spin-out from Oxford University, working to prevent brain haemorrhage by cu...
News
/ Thu 8 Apr 2021